CAS 32652-17-8

Fórmula: C6H11NaO4

InChI: InChI=1S/C6H12O4.Na/c1-6(10,2-3-7)4-5(8)9;/h7,10H,2-4H2,1H3,(H,8,9);/q;+1/p-1/t6-;/m1./s1

Clave InChI: RIYNLCMADQUBEM-FYZOBXCZSA-M

SMILES: C[C@@](CCO)(CC(=O)[O-])O.[Na+]

L-Mevalonic Acid Sodium Salt

CAS: 32652-17-8

Fórmula: C₆H₁₁O₄·Na

Peso molecular: 147.15 22.99

Ref: 4Z-M-673

L-Mevalonic Acid Lithium Salt (>90%)

Producto controlado

CAS: 32652-17-8

Stability Hygroscopic
Applications L-Isomer of Mevalonic acid (M339020), a precursor in the biosynthesis of cholesterol (C432501).
References Arigoni, D., et al.: J. Chem. Soc., 21, 1394 (1970); Cornforth, R.H., et al.: Tetrahedron., 18, 1351 (1962);

Fórmula: C₆H₁₁LiO₄

Pureza: >90%

Forma y color: Neat

Peso molecular: 154.09

Ref: TR-M339035

L-Mevalonic acid lithium salt

CAS: 32652-17-8

L-Mevalonic acid lithium salt is an analog of mevalonic acid, a key intermediate in the biosynthesis of cholesterol and other important biomolecules. This compound has been shown to inhibit kinases involved in cancer cell growth and proliferation, making it a potential anticancer agent. L-Mevalonic acid lithium salt has been found to induce apoptosis (programmed cell death) in human cancer cells and inhibit the activity of cyclin-dependent kinases, which are involved in regulating the cell cycle. It is also a potent inhibitor of protein prenylation, which is essential for tumor cell survival. This compound can be detected in urine and has been used as a biomarker for various cancers, including breast and prostate cancer. Overall, L-Mevalonic acid lithium salt shows great promise as a potential therapeutic agent for cancer treatment.

Fórmula: C₆H₁₁NaO₄

Pureza: Min. 95%

Peso molecular: 170.14 g/mol

Ref: 3D-HBA65217